Dr. Lee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2200 Ofarrell St
San Francisco, CA 94115Phone+1 415-833-2000
Education & Training
University of California (San Francisco)Residency, Pediatrics, 1992 - 1995
David Geffen School of Medicine at UCLAClass of 1992
Certifications & Licensure
CA State Medical License 1994 - 2025
NM State Medical License 1996 - 1997
Awards, Honors, & Recognition
- Fellow (FAAP) American Academy of Pediatrics
Publications & Presentations
PubMed
- 73 citationsClinical Response to Immunotherapy Targeting Programmed Cell Death Receptor 1/Programmed Cell Death Ligand 1 in Patients With Treatment-Resistant Microsatellite Stable...Chongkai Wang, Jaideep Sandhu, Ching Ouyang, Jian Ye, Peter P. Lee
JAMA Network Open. 2021-08-02 - 39 citationsPhase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancer.Yuan Yuan, Jin Sun Lee, Susan E. Yost, Paul Frankel, Christopher Ruel
European Journal of Cancer. 2021-07-01 - 21 citationsSpatial distribution of B cells and lymphocyte clusters as a predictor of triple-negative breast cancer outcome.Juliana C. Wortman, Ting-Fang He, Shawn Solomon, Robert Z. Zhang, Anthony Rosario
NPJ Breast Cancer. 2021-07-01
Press Mentions
Stand up to Cancer Awards 5 'Phillip A. Sharp Innovation in Collaboration' GrantsMay 2nd, 2019
Lakehead University Hosting Discussion on the Impact of Mercury ContaminationMarch 1st, 2017
Grant Support
- Interplay Between Cancer And Immune Cells On Targeted TherapyNational Cancer Institute2008–2012
- Immune Profile Analysis Of Tumor-Draining Lymph Nodes In Breast CancerNational Cancer Institute2007–2011
- Characterization Of Tumor Specific T Cells In MelanomaNational Cancer Institute2001–2005
- Endogenous T Cell Responses To MelanomaNational Cancer Institute1999–2001
- Endogenous T Cell Responses To LeukemiaNational Cancer Institute1997–1998
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
